maropitant has been researched along with minocycline in 1 studies
| Studies (maropitant) | Trials (maropitant) | Recent Studies (post-2010) (maropitant) | Studies (minocycline) | Trials (minocycline) | Recent Studies (post-2010) (minocycline) |
|---|---|---|---|---|---|
| 74 | 36 | 56 | 6,579 | 502 | 2,921 |
| Protein | Taxonomy | maropitant (IC50) | minocycline (IC50) |
|---|---|---|---|
| Multidrug transporter MdfA | Escherichia coli K-12 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, M; Aguado, D; Benito, J; García-Fernández, J; Gómez de Segura, IA | 1 |
1 other study(ies) available for maropitant and minocycline
| Article | Year |
|---|---|
Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a randomised laboratory study.
Topics: Amitriptyline; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Hyperalgesia; Male; Methyl Ethers; Minocycline; Nociception; Pain Threshold; Piperidines; Pulmonary Alveoli; Quinuclidines; Random Allocation; Rats, Wistar; Remifentanil; Sevoflurane | 2015 |